TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ASMB

Assembly Biosciences, Inc. - Common Stock

NASDAQ
$22.50
▲ $2.41 (+12.0%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 17 Nov 2026
H $37.01L $19.20-27.0%
$37.01$33.45$29.89$26.32$22.76$19.2$22.5
RSI (14)
Intraday · 15-minBuy+15RSI 61UptrendMACD Bearishfor day-trading context — not advice

Technical signal

Strong sell-50
RSI (14)56
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Above upper band
vs 20-day
above
vs 50-day
below
vs 200-day
below
Support
$19.20
Resistance
$22.69
  • Price is below its 50-day average (medium-term weakness).
  • Price is above the upper Bollinger Band (stretched to the upside).

Signal backtest · 2026-02-17 → 2026-11-17

Strategy return
-36.4%
Buy & hold
-19.1%
Trades
14
Win rate
7%

$100,000.00 invested would be worth $63,570.30 (-36.4%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Assembly Biosciences, Inc.· Biotechnology

source: yahoo

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Sector
Healthcare
Industry
Biotechnology
Employees
73
Headquarters
South San Francisco, United States
www.assemblybio.com ↗

Fundamentals

source: yahoo
Market cap
$454.39M
P/E
29.6
P/B
1.5
EPS
$0.75
Div yield
0.0%
Profit margin
-16.6%
ROE
-4.6%
Debt / Equity
0.01
Beta
1.22
52-week range
$19.20 – $39.65
52-week low · $19.2016% of rangehigh · $39.65

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▼ Negative1↑ · 2↓ · 5–
  • Assembly Biosciences (ASMB) Reports Q3 Loss, Lags Revenue Estimates▼ Negative
    Zacks · 12 Nov 2026
  • Assembly Biosciences: Q3 Earnings Snapshot— Neutral
    Associated Press · 12 Nov 2026
  • Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates— Neutral
    GlobeNewswire · 12 Nov 2026
  • Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

▼ Negative
Zacks · 12 Nov 2026
  • Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates▲ Positive
    Zacks · 05 Nov 2026
  • Assembly Biosciences to Participate in Upcoming Investor Conferences— Neutral
    GlobeNewswire · 02 Nov 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.